News & Events


  • 1 October 2013: DNAlytics moves from UCL facilities to its new location in CEI2, still in Louvain-la-Neuve.
  • 30 May 2013: GSK Vaccines announces the approval by the FDA of two melanoma therapeutic vaccines. Those vaccinces incorporate at population stratification into responders and non-responders. This really innovative predictive strategy has been co-developed by DNAlytics founders Pierre Dupont and Thibault Helleputte: Method for classifying a cancer patient as responder or non-responder to immunotherapy.
  • 18 April 2013: DNAlytics is the winner of the startup pitch session at Mind&Market 2013. Louvain-la-Neuve, Belgium.
  • March 2013: DNAlytics is selected as finalist for the eHealth Solution EU SME Competition 2013, organized during the eHealth week by the European Commission in Dublin, Ireland, on 13 May 2013.
  • March 2013: A scientific abstract describing Rheumakit, an early diagnostic solution for patients with arthritis has been selected as winner of the "Inspiring young scientist" competition at Knowledge for Growth, organized by FlandersBio and taking place in Ghent on 30 May 2013.
  • January 2013: DNAlytics releases BLISS (Biomarker List Interpretation Simple Software). BLISS is available in a Software as a Service (SaaS) mode.
  • October 2012: DNAlytics receives the support of the Caring Entrepreneurship Fund, managed by King Baudouin Foundation and at the initiative of M Roch Doliveux, UCB's CEO.
  • 26 September 2012: DNAlytics announces the release of RheumaKit, a diagnostic solution for patients with arthritis.
  • 10 September 2012 - DNAlytics defends its project before the UCL Technology Transfer Council and officially gets the "UCL Spin Off Status".
  • 10 April 2012 - DNAlytics becomes a registered trademark.
  • 14 December 2011 - DNAlytics received the Innovation Prize from the Microsoft Innovation Center Belgium. Read more here.
  • 13 December 2011 - Thibault Helleputte received the IBM Belgium / FRS-FNRS Award for its PhDThesis, which contributes to DNAlytics technology. Read more here.

Upcoming Events

  • 4 December 2013 - Pharma Cafe: La Therapie Biotechnologique est-elle facilitee ou freinee par les procedures d'enregistrement et de remboursement? Brussels, Belgium.

Past Events This Year

Former Events




  • DNAlytics attended the Pharma-Connexion event on 15 December 2010 in Gembloux, Belgium.
  • DNAlytics attended the Biowin Day on 8 December 2010 in Louvain-la-Neuve, Belgium.
  • DNAlytics attended the 7th call for projects of Biowin on 23 November 2010 in Gosselies, Belgium.